Physician profile
Robert L Hole
NPI 1982795241
$1,753.07
in general payments reported to CMS, 2019-2025
22 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $26.93 · 2021: $180 · 2022: $479 · 2023: $101 · 2024: $270 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.77 |
| Education | $136.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $360.42 | 2021-2023 | Mako, Sharpshooter |
| Zimmer Biomet Holdings, INC. | $204.02 | 2021-2025 | Comprehensive, Tapestry |
| Kerecis Limited | $152.51 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Nuvasive, INC. | $141.13 | 2019 | |
| Fidia Pharma USA INC. | $136.68 | 2019-2025 | Hymovis |
| Arteriocyte Medical Systems, INC. | $136.36 | 2019 | |
| Depuy Synthes Sales INC. | $130.20 | 2021-2023 | Twistr, Truespan Orthocord, Rigidloop |
| Treace Medical Concepts, INC. | $106.31 | 2022 | |
| Dynasplint Systems INC. | $51.18 | 2024 | Dynasplint |
| Pacira Pharmaceuticals Incorporated | $38.95 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.00 | 2025 | |
| Heraeus Medical, LLC. | $30.82 | 2021-2023 | Palacos |
| Djo, LLC | $28.86 | 2025 | Cmf |
| Alexion Pharmaceuticals, INC. | $28.28 | 2024 | |
| Baudax Bio INC. | $26.93 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $25.53 | 2019 | |
| Avanos Medical | $25.07 | 2025 | Trivisc Sodium Hyaluronate |
| Seapearl East, INC | $22.50 | 2025 | |
| Orthofix Medical, INC. | $22.28 | 2025 | Physio-Stim |
| Linkbio Corp | $20.26 | 2025 | |
| Medacta USA, INC. | $18.07 | 2025 | Primary Shoulder |
| Horizon Therapeutics Plc | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.